We are one of the leading generic pharmaceutical companies in Central Eastern Europe, our activities incorporate all areas of the pharmaceutical value chain. Egis is a member of Servier, a global pharmaceutical group governed by a Foundation.
In the 2022/2023 business year Egis Group generated net sales of EUR 631.7 million. Besides Hungary, we sell our products under Egis’ brand names in 18 countries through our network of subsidiaries and representative offices.
Our products (active ingredients, tablets, injections, galenic formulations etc.) are available in 100 countries in total through our network of subsidiaries, representative offices or partners. 
Our focus lies on treating diseases of the cardiovascular and central nervous systems and we also provide modern treatment solutions in the fields of diabetology, skin and wound care. In 2013, we launched our first biosimilar monoclonal antibody (mAb) product, it was also the first mAb in the European Union. Since then, we launched 3 more biosimilar drugs.
As one of the companies in the CEE region committed to innovation, we devote more than EUR 45 million yearly to R&D. Our research and development activities focus on high-quality, value-added branded generic products.
In the last 20 years, we have invested more than EUR 770 million in improvements in Hungary: we modernized the complete process of finished product manufacturing and established state-of-the-art R&D centres. In Budapest the development of drugs substances and finished products having significant biological activity in very small doses has become possible and the comprehensive modernization of the traditional technology of active ingredient manufacturing has been completed. 
Large-scale developments at our site in Körmend: inauguration of a new galenic plant (Sept 2019); the major extension of the packaging plant was completed and capacity to manufacture special medicines - typically oncology products - was established (both 2021 autumn).

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Therapeutics

Egis Pharmaceuticals PLC

Csaba Poroszlai

Miquel Marti

This department ensures the integrity and compliance of products and services through systematic quality checks, audits, and assessments.

Quality Assurance Management

This department oversees the development and strategy of products, ensuring alignment with market needs and company goals.

Product Management

This department focuses on promoting and selling medical products and services to healthcare providers.

Medical Sales

This department manages compliance with regulations and oversees the submission of necessary documentation to ensure product approval and safety.

Regulatory Affairs

This department manages employee relations, recruitment, and organizational development initiatives.

Human Resources

This department oversees the planning, execution, and completion of projects, ensuring they align with organizational goals and are delivered on time and within budget.

Egis Pharmaceuticals PLC

Org chart

Teams

Quality Assurance Management

Product Management

Medical Sales

Regulatory Affairs

Human Resources

Project Management

Offices

Egis Pharmaceuticals PLC

Org chart

Teams

Quality Assurance Management

Product Management

Medical Sales

Regulatory Affairs

Human Resources

Project Management

Offices

Related companies